Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine

We report the case of a 33-year-old male who presented with unilateral central serous retinopathy three days after the injection of a COVID-19 vaccine. A 33-year-old healthy Hispanic male referred to the ophthalmology service due to blurry vision and metamorphopsia in the right eye without any flash...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology case reports 2021-09, Vol.23, p.101136, Article 101136
Main Authors: Fowler, Nicholas, Mendez Martinez, Noe R., Pallares, Bernardo Velazquez, Maldonado, Ramiro S.
Format: Article
Language:English
Subjects:
Case Report
Central serous retinopathy
COVID-19
CSR
mRNA vaccine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report the case of a 33-year-old male who presented with unilateral central serous retinopathy three days after the injection of a COVID-19 vaccine. A 33-year-old healthy Hispanic male referred to the ophthalmology service due to blurry vision and metamorphopsia in the right eye without any flashes, floaters, eye redness or pain. The patient reported that 69 hours prior to presentation he received the first dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine. He denied any past ocular history or pertinent medical history. He does not take any medicines and denies stressful factors in his life. The clinical examination and imaging tests were consistent with central serous retinopathy that resolved in three months. This is the first report of an ocular complication potentially associated with a COVID-19 vaccination. Our case contributes information of a side effect potentially related to this new vaccine.
ISSN:2451-9936
2451-9936
DOI:10.1016/j.ajoc.2021.101136